BioCentury
ARTICLE | Clinical News

Zinplava bezlotoxumab regulatory update

October 31, 2016 7:00 AM UTC

FDA approved a BLA for Zinplava bezlotoxumab from Merck to reduce recurrence of Clostridium difficile infection (CDI) in adults receiving antibacterial drug treatment of CDI and are at high risk for r...